Reuters - GSK Puts Lucozade and Ribena Drink Brands Up for Sale

GlaxoSmithKline is to sell soft drink brands Lucozade and Ribena in a move analysts believe will raise over 1 billion pounds ($1.5 billion) and focus its consumer health business on global products, writes Reuters. The plan was announced alongside first-quarter results that saw sales at Britain's biggest drugmaker drop a slightly smaller-than-expected 3 percent from a year ago.

DealsNorth AmericaUSBriefs